Prime Minister Narendra Modi on Thursday told South African President Cyril Ramaphosa that India's considerable productive capacity for pharmaceuticals and vaccines would continue to serve the needs of all countries, including those in Africa.
Modi and Ramaphosa, during a telephonic conversation, discussed the continuing challenges posed by the COVID-19 pandemic, and in this context the vaccination campaigns being undertaken in their respective countries, a Prime Minister's Office (PMO) statement said.
"Spoke to President @CyrilRamaphosa about the measures India and South Africa are taking to fight the COVID-19 pandemic domestically and internationally. India's capacity to produce medicines and vaccines is supporting the efforts of many nations, including our friends in Africa," Modi said in a tweet.
The PMO also said in its statement that the prime minister reiterated to the South African president that India's considerable productive capacity for pharmaceuticals and vaccines would continue to serve the needs of all countries, including those in Africa.
The two leaders also discussed possibilities of collaboration between India and South Africa in various international fora, to facilitate access and affordability of vaccines and medicines.
Modi and Ramphosa agreed that officials of both countries would remain in touch over the coming days to exchange experiences and explore potential for collaborative efforts against the pandemic, according to the PMO.
Earlier this week, made-in-India vaccines reached South Africa in an aircraft and President Ramaphosa received the consignment of doses.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)